As Rowse expands from skincare to make-up, Wallpaper* speaks exclusively with co-founders Nuria Val and Gabriela Salord about ...

Enjoy 12 digital issues a year from the global design authority Choose a print or digital subscription, or both ...

Vir Biotechnology VIR is set to give its latest quarterly earnings report on Wednesday, 2025-05-07. Here's what investors need to know before the announcement. Analysts estimate that Vir ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Legend Biotech USA Inc. CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $369 million Over 6,000 patients treated to date Initiated CARVYKTI ® clinical ...

Hong Kong-based venture capital firm ORI Capital plans to launch a new fund to invest in Chinese healthcare start-ups, as the domestic biotechnology industry experiences its own “DeepSeek moment ...

Xoted Biotechnology Labs, a subsidiary of DRC Ventures, will establish its new research and development center at The Spark Center at Spartanburg Community College's Tyger River Campus in Duncan.

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top ...

Shares of Septerna Inc. were soaring in Wednesday trading after the biotech clinched a partnership with Wegovy and Ozempic parent Novo Nordisk to collaborate on oral obesity and Type 2 diabetes ...

Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into aging, is now laying off every one of its remaining employees.

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Vinay Prasad's appointment as CBER director has caused biotech stocks to fall due to concerns over potential regulatory changes. Prasad's history of criticizing FDA decisions suggests possible ...